Spasm: Clinical Trials

1 trial for Spasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Spasm: new trials by email Literature Review of Spasm trials Research Report on Spasm

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)
SHP465 - Attention Deficit Hyperactivity Disorder (ADHD)
Phase 3TerminatedShire1412018-01-022021-06-03

Narrower conditions

Attention Deficit Disorder with Hyperactivity (1)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurodevelopmental Disorders (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Sponsors

Shire (1)

Countries

United States (1)